drugset / Trial / NCT04501653
Precision Functional Brain Mapping in Psilocybin
RandomizedCrossoverSingle-blindBasic science
Summary
This project will employ functional brain imaging to study the mechanism and immediate and long-term effects of psilocybin, a serotonin receptor 2A agonist, on cortical and cortico-subcortical brain networks in healthy adults.
Timeline
- Start
- 2021-06-01
- Primary completion
- 2023-03-19
- Completion
- 2023-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylphenidate | Small molecule | 40 mg | Oral |
| Subject | Psilocybin | Other / unclassified | 25 mg | Oral |
Indications
No indication recorded.